Related Articles
PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review)
Significance of PD‑L1 clones and C‑MET expression in hepatocellular carcinoma
PD‑1/PD‑L1 inhibitor‑based immunotherapy in locally advanced or metastatic triple‑negative breast cancer: A meta‑analysis
Tumor microenvironment classification based on T‑cell infiltration and PD‑L1 in patients with mismatch repair‑proficient and ‑deficient colorectal cancer
PD‑L1 and PD‑1 expression correlate with prognosis in extrahepatic cholangiocarcinoma